3vfq: Difference between revisions

Revision as of 10:22, 18 January 2012 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,331,613 edits m Protected "3vfq" [edit=sysop:move=sysop] ← Older edit		Revision as of 06:04, 25 January 2012 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,331,613 edits No edit summary Newer edit →
Line 5:		Line 5:
	Authors: Karlberg, T., Thorsell, A.G., Arrowsmith, C.H., Bountra, C., Edwards, A.M., Ekblad, T., Weigelt, J., Schuler, H., Structural Genomics Consortium (SGC)		Authors: Karlberg, T., Thorsell, A.G., Arrowsmith, C.H., Bountra, C., Edwards, A.M., Ekblad, T., Weigelt, J., Schuler, H., Structural Genomics Consortium (SGC)

	Description: ~~HUMAN~~ PARP14 (ARTD8, BAL2) -~~MACRO DOMAINS~~ 1 ~~AND~~ 2 ~~IN COMPLEX WITH ADENOSINE~~-5-~~DIPHOSPHORIBOSE~~		Description: Human PARP14 (ARTD8, BAL2) -macro domains 1 and 2 in complex with adenosine-5-diphosphoribose

Navigation menu